FOLD | Amicus therapeutics, inc - Stock Value & PE Ratio Analysis

3

24

15

Average Growth

AI analysis rates FOLD with a medium value score of 3.
It is mainly due to stable revenue growth, but with concerns regarding unstable operating cash flow.
Over the past 3 months, FOLD has maintained a consecutive value rating of 3.0, close to the rating of 3.0 over the past 3 years, indicating stable enterprise value.
Compared to all stocks in the Health Care sector, FOLD has a medium value rating.

FOLD Value Reference Factors

The Value score is derived from various data and factor information, integrated through AI algorithms. The following factors are part of the evaluation used by AI value scores.

Update to 2025/05/03 (Weekly Update)

FOLD Financial Forecast

Unit : USD

Update to 2025/5/4 (Quarterly Update)

FOLD Earnings Table

Unit : USD

QTR	Non-GAAP EPS	EPS YoY	EPS Surprise %	Sales	Sales YoY	Sales Surprise %	NPM
Current	0.09	181.8%	350%	149.71M	30.1%	1.2%	-4.8%
2024Q2	0.1	242.9%	25%	141.52M	36.7%	-4%	-12.4%
2024Q1	0.06	140%	9.8%	126.67M	34%	4.5%	-43.9%
2023Q4	-0.02	88.9%	-66.7%	110.4M	28%	-0.7%	-29.4%
2023Q3	-0.11	42.1%	83.3%	115.08M	30.6%	0.7%	-20.8%

Update to 2025/5/8 (Quarterly Update)

FOLD Historical Value Score

You can use historical scores of 3 or above to observe potential performance and make investment decisions.

FOLD Value Strategy Backtest

The following backtest is based on specified rules since 2007. Price chart shows buy/sell time, cumulative returns, and backtesting statistics.

Entry

Exit

The Backtest Result of FOLD from 2007/06 till Now

6.47%
Cumulative Return: 0.35%
Annual Return: 53.58%
Volatility: 0.01
Sharpe Ratio

Statistics data for entering at or above a Value score of 4 and exiting at or below a Value score of 2 from June, 2007 to May, 2025. (Total Trades: 1)